

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1442, 2004-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Spotlight on Almotriptan in Migraine
By Keam S.J. Goa K.L. Figgitt D.P.
CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. :



